title: [Screening for cancer - economic consideration and cost-effectiveness].
abstract: Cost-effectiveness analysis has become an accepted method to evaluate medical technology and allocate scarce health-care resources. Published decision analyses show that screening for cancer in general is cost-effective. However, cost-effectiveness analyses are only as good as the clinical data and the results are sensitive to the chosen methods and perspective of the analysis.
authors.affiliation: KORA, Købmagergade 22, 1050 København K. jakj@kora.dk.
authors.forename: Jakob
authors.initials: J
authors.lastname: Kjellberg
mesh_terms: D003362:Cost-Benefit Analysis / Q000379:methods*; D003718:Denmark; D055088:Early Detection of Cancer / Q000191:economics*; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D009369:Neoplasms / Q000175:diagnosis* / Q000191:economics